Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
February 07 2005 - 7:15AM
PR Newswire (US)
Amylin Pharmaceuticals to Present at Merrill Lynch Global
Pharmaceutical, Biotechnology & Medical Device Conference SAN
DIEGO, Feb. 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (NASDAQ:AMLN) will be presenting at the Merrill Lynch Global
Pharmaceutical, Biotechnology & Medical Device Conference on
Thursday, February 10, 2005 at 9:30 a.m. ET in New York. Daniel
Bradbury, Chief Operating Officer of Amylin Pharmaceuticals, will
be providing a corporate overview. The live presentation will be
webcast, and a recording will be made available following the
event. The webcast and recording will be accessible through
Amylin's corporate website, located at http://www.amylin.com/. To
access the live webcast, please log on to Amylin's site
approximately fifteen minutes prior to the presentation to register
and download any necessary audio software. Amylin Pharmaceuticals
is committed to improving the lives of people with diabetes and
other metabolic diseases through the discovery, development and
commercialization of innovative, cost-effective medicines.
DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta,
Vice President of Finance and Chief Financial Officer of Amylin
Pharmaceuticals, Inc., +1-858-552-2200 Web site:
http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024